Trial description:
A phase III, double blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours
Contact name:
Dr Luke Hughes-Davies
Trial start date:
Monday, December 21, 2015
Trial end date:
Saturday, December 11, 2021
Trial tumour type:
Breast
Colorectal
Oesophageal
Prostate
Show on Radiotherapy:
No
